Skip to content

Prospective observational study to determine the incidence of hospital admissions due to post-operative bleeding in outpatient treatment of endoscopic submucosal dissection for gastric tumours

Prospective observational study to determine the incidence of hospital admissions due to post-operative bleeding in outpatient treatment of endoscopic submucosal dissection for gastric tumours. - Prospective observational study to determine the incidence of hospital admissions due to post-operative bleeding in outpatient gastric ESD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053830
Enrollment
160
Registered
2024-03-13
Start date
2024-03-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric epithelial tumor

Interventions

None listed

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients planning to undergo gastric ESD and closure of post-ESD mucosal defect using endoscopic hand suturing (EHS) as an outpatient treatment 2. Preoperative diagnosis of gastric cancer or gastric adenoma (including suspected) of 3 cm or less 3. No endoscopic findings that suggest submucosal invasion 4. Patients aged between 20 and 85 years at the time of consent 5. Patients who give written consent to participate in this study

Exclusion criteria

Exclusion criteria: 1. Patients treated for multiple lesions at the same time (patients with multiple lesions, including those of other organs, can be included if only one lesion is treated during the protocol treatment period). 2. Patients with a history of previous gastrectomy. 3. Severe organ failure (heart, lung, liver, kidney, bone marrow). 4. Patients with lesions located on areas considered extremely difficult to treat (gastric fornix, pylorus) 5. Patients who cannot be managed perioperatively with antithrombotic agents according to the guidelines of the Japanese Gastrointestinal Endoscopy Society 6. A case that the attending physician determines that patient is not suitable for this study 7. A case that patient refuses to participate in this study after enrollment.

Design outcomes

Primary

MeasureTime frame
Incidence of hospital admissions due to post-operative bleeding

Secondary

MeasureTime frame
Procedure outcomes (Resection rate, success rate of closure, procedure time, incidence of intra-operative adverse events), incidence of post-operative adverse events, total medical costs incurred during treatment and within 28 days after treatment

Countries

Japan

Contacts

Public ContactTeppei Akimoto

Keio University School of Medicine Division of Research and Development for Minimally Invasive Treatment, Cancer Center

t-akimoto@keio.jp03-5363-3437

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026